- Catalogs
- Itamar Medical
- EndoPAT®️
EndoPAT®️
EndoPAT®️
Endothelial Dysfunction is a critical indicator of vascular health and an independent risk factor for cardiovascular disease (CVD). It involves damage to the endothelium, the inner layer of blood vessels, affecting processes like vasodilation, inflammation, and coagulation, collectively known as VIOPAC. This dysfunction is treatable and reversible with medical intervention and lifestyle changes.
EndoPAT is a non-invasive, FDA-cleared device designed to diagnose endothelial dysfunction. It uses Peripheral Arterial Tone (PAT) technology, validated in numerous clinical trials, to assess small vessel health. The test is quick, lasting 15 minutes, and is both operator and interpreter independent.
EndoPAT is clinically validated and serves as a predictor of CVD, aiding in risk stratification and patient management. It measures small vessels' response to reactive hyperemia, correlating with cardiovascular small vessel disease. The device is accurate, reproducible, and corrects for baseline vessel size and non-endothelial changes.
EndoPAT is used in various clinical scenarios, including CVD prediction, diabetes management, women's health, erectile dysfunction, lifestyle modification, and occupational screening. It provides a novel risk factor for patient restratification, treatment titration, and monitoring patient compliance.
The RHI score, provided on a logarithmic scale, indicates endothelial function. Scores above 0.7 suggest healthy endothelial function, while scores below 0.51 indicate dysfunction. The test involves measuring dilatory response through pulsatile volume changes at the fingertips.
EndoPAT results guide lifestyle modifications and pharmacological interventions to improve endothelial function. Regular assessments help in treatment adjustment and monitoring, especially for high-risk patients with underlying cardiovascular conditions.
EndoPAT, developed by Itamar Medical, offers a non-invasive approach to early-stage disease detection and patient care improvement. It is supported by extensive research and is recommended by leading cardiovascular health researchers.
Catalog excerpts
Simply Assessing Vascular Health Health-Being Made Simple
Open the catalog to page 1
Endothelial Dysfunction - The Earliest Clinically Detectable Marker of Vascular Health Endothelial Dysfunction, a common indicator of the health of the vessels, is widely validated as an independent risk factor for cardiovascular disease (CVD) and other life threatening diseases. Damage to the endothelium, the most inner layer of vessels, plays a major role in the development of CVD and in the progress of the disease and eventually its outcomes. The health of the vessels reflects a wide range of sophisticated biological and physiological processes regulated by the endothelium, a ‘super organ’...
Open the catalog to page 2
How Does EndoPAT Work? EndoPAT measures dilatory response through pulsatile volume changes at the finger tips (PAT signal). The signals are interpreted according to a unique algorithm which produces the RHI score – a metric index of Endothelial Dysfunction. 2. Once the cuff is released, blood flow is restored causing the release of dilating compounds such as NO and EDHF by the endothelium. The larger the dilatory response is, the healthier the Endothelial Function. 3. EndoPAT’s software performs an automatic analysis of data obtained from both fingers and provides a post-occlusion to pre-occlusion...
Open the catalog to page 3
Implementing the EndoPAT Test Results Life style modifications (such as smoking cessation, dietary change, exercise etc.) as well as proper pharmacological intervention can positively impact endothelial function within a relatively short time, and may have ramifications on therapeutic management and monitoring protocols. Endothelial Dysfunction Low/Mid Risk Patients No underlying CV disease and/or conditions 1. Promote and follow lifestyle modifications. 2. Consider use of medications such as statins, aspirin. 3. Refer patient for further assessment of potential underlying conditions. 4. Perform...
Open the catalog to page 4
Simple Assessing Vascular Health Itamar Medical is a leading medical device company that develops, manufactures and markets diagnostic products based on its proprietary PAT (Peripheral Arterial Tone) Signal. The PAT signal is a non-invasive “window” to the cardiovascular system and the autonomic nervous system. PAT based products provide early-stage detection of disease and facilitate follow-ups; improving patient care while reducing the overall cost of healthcare. Itamar Medical has offices and distribution channels around the world. Health Being Made Simpl
Open the catalog to page 5All Itamar Medical catalogs and technical brochures
WatchPAT®️ 3008 Pages
WatchPAT® ONE2 Pages
The PAT ® Signal1 Page